In neuropsychiatry, the PFC is commonly divided into three main divisions: the medial PFC (containing the anterior cingulate and paracingulate cortices), the orbital PFC, and the dorsolateral PFC. Medial PFC functions relevant to fear include attention to the emotional states of the self and others, guidance of response selection by emotional states, and suppression of fear-related behavioral responses as situations change.
+15,+19,+22 Orbital PFC functions relevant to fear include modulation of behavioral and visceral responses associated with fear-related situations as situations change and modulation of emotional responses by correcting associations when they become inappropriate.
+19,+44 Dorsolateral functions relevant to fear are believed to include involvement in working memory, response preparation and response selection.
+44
The amygdala has reciprocal connections with orbital and medial PFC and is indirectly connected to the dorsolateral PFC. Orbital and medial PFC appear to exert a predominantly inhibitory influence upon the amygdala by activation of inhibitory interneurons (top-down modulation).
+13,+15,+22 Several recent functional magnetic resonance imaging (fMRI) studies in normal subjects support top-down modulation of emotions by these areas of PFC. One group has compared patterns of brain activation while subjects perform tasks requiring conscious evaluation of emotionally arousing pictures versus simple matching tasks using the same pictures (
+Figure 2).
+4,+5 When the 2 conditions were compared, stronger activation of the ventral PFC (BA 44/45 and 47) by the more complex evaluative tasks was associated with decreased activation of the amygdala. During the simple matching tasks, which evoked less activation of the ventral PFC, stronger activation of the amygdala was demonstrated. Autonomic reactivity as monitored by changes in skin conductance correlated with activation of the amygdala. A similar inverse correlation between activity in the amygdala and ventral PFC was also found in a study using subliminal priming with emotionally arousing stimuli.
+3 In addition, both a gender-decision task and an emotion-identification task evoked less activation in the amygdala and more in ventral PFC than passive viewing of the same images.
+45
Modulation of the amygdala by the PFC may be one of the biological mechanisms which underlie the effectiveness of cognitive behavioral therapy (CBT) in anxiety disorders.
+10,+46,+47 Similarities exist between extinction (in which a learned fear response is replaced or overlaid by new learning) and CBT.
+10,+47,+48 Two small studies have employed functional imaging to monitor the brain’s response to symptom provocation in patients with phobias (spider and social phobias) prior to and following therapeutic interventions (CBT was utilized in both studies and compared to treatment with citalopram in one).
+6,+49 In both studies patients that responded successfully to therapy exhibited decreased activity in limbic-related areas. In the study of patients with spider phobia, activation (measured by fMRI) in dorsolateral PFC (BA 10) and the parahippocampal gyrus during exposure to film excerpts depicting spiders was no longer found following successful completion of CBT.
+49 Similarly, in the study of patients with social phobia, those that responded well to either CBT or citalopram had decreased regional cerebral blood flow (measured by positron emission tomography) in the amygdala and hippocampus as well as periamygdaloid, parahippocampal, and rhinal cortices while performing a public speaking task (Figure 3).
+6 In addition, the decrease in blood flow in the amygdala prior to and following treatment correlated with long-term clinical outcome. Both authors note that these results indicate that CBT is able to modify the abnormal neural functioning underlying anxiety disorders, perhaps by deconditioning or habituating contextual fear.
There is experimental evidence that extinction of fear can be facilitated by manipulation of neurotransmitters, specifically via the
N-methyl-d-aspartate (NMDA) glutamate receptor.
+50 In animal studies administration of D-4-amino-3-isoxazolidone (D-cycloserine, DCS) after extinction trials enhanced extinction. DCS is a partial agonist for the NMDA receptor, acting at the strychnine-insensitive glycine-recognition site. Efficacy of this approach for enhancing treatment of phobia was recently tested in a small double-blind placebo-controlled study.
+51 Patients with acrophobia were randomly assigned to receive a high dose of DCS (500mg), a low dose (50mg) or placebo prior to 2 sessions of virtual reality therapy separated by 1-2 weeks. Presence of DCS did not affect level of fear exhibited during the first session, indicating no direct anxiolytic effect. During the second session and at follow up 1 week and 3 months later the patients that received DCS prior to therapy sessions exhibited significantly reduced fear of heights. These findings suggest that DCS may be a useful adjunct to therapeutic interventions for disorders in which fear-related learning is an important component.
Converging evidence supports the theory that genetic differences may influence development and/or expression of anxiety disorders. Increased reactivity of the amygdala has been demonstrated in individuals with a polymorphism in the promoter region of the serotonin transporter gene.
+52,+53 Presence of this polymorphism has been associated with susceptibility to fear conditioning as well as increased expression of anxiety and affective illness.
+54—+56 In patients with social phobia its presence is associated with both greater symptom severity and amygdala excitability.
+53 It has been suggested that it may be associated with greater vulnerability to life stress.
+57 These results are consistent with studies supporting a genetic component to all 3 phases of fear conditioning (acquisition, habituation, extinction).
+58 It is likely that there is life-long interaction between biological factors (e.g., genetic) and environment in the establishment and re-modeling of networks involving fear and fear memory.
Functional imaging has demonstrated hyperexcitability of the amygdala in various anxiety disorders. Often an inverse relationship exists between activity in the amygdala and areas in PFC.
+47 Recent studies illustrate this for social phobia and posttraumatic stress disorder (PTSD). Patients with social phobia exhibited increased regional cerebral blood flow (rCBF) (measured by PET) in the amygdala/periamygdaloid cortex during a public speaking task compared to controls.
+59 At the same time, rCBF in orbital PFC decreased in the patients and increased in the controls. In another study, activation of the amygdala (measured by fMRI) did not differ between patient and control groups when viewing fearful or neutral faces (compared to happy faces).
+40 However, the patients demonstrated significantly greater activation than controls in the amygdala and nearby cortex when viewing contemptuous or angry faces, indicating specificity related to their disorder. Larger than normal activations in the amygdala have also been measured in patients with social phobia during all phases of aversive conditioning (habituation, conditioning, extinction).
+60 Patients with PTSD have also exhibited increased reactivity of the amygdala (measured by PET or fMRI).
+1,+61,+62 Furthermore, measures of PTSD symptom severity were positively correlated with rCBF in the amygdala and inversely correlated with rCBF in medial PFC in one study.
+62 Regional CBF in the 2 areas was inversely related.